A pharmaceutical composition for the treatment of colorectal disease comprising the fermentative products of Kalopanax septemlobus as an active ingredient

摘要

The present invention relates to a pharmaceutical composition and a food composition for the treatment of colon disease, comprising the Eumnamu fermented product as an active ingredient. In the field of oriental medicine, the antibacterial and anti-inflammatory effects of Eumnamu have been disclosed, and technologies such as the use of Eumnamu extract to treat tuberculosis or acne have been developed, but the efficacy of Eumnamu related to colon disease has not been known. Eumnamu, or Eumnamu fermented product of the present invention has a remarkable effect on treating colitis in an individual with colitis-induced colon disease. In particular, the fermented Eumnamu fermented product that has been fermented with basidiomycete mycelium or is bioconverted through additional enzymatic treatment has a more remarkable effect on the treatment of colon diseases than that of the unfermented Eumnamu plant, so it is expected to be widely used in the treatment of various colon diseases in the medical field. It is expected.